PulmoBioMed raises £1.4m for innovative lung test commercialization

PulmoBioMed – a Northumbria University spin-out which has developed a new lung test that could lead to earlier diagnosis of asthma and other conditions – has raised £1.4m to help commercialize its technology.

UnitedHealth Group names next insurance CEO, following top executive’s murder

Sign up for free to read a limited number of articles each month. Pick what newsletters get delivered to your inbox each week. Biopharma ENDPOINTS

January 24, 2025

New epigenetic clocks distinguish aging causes and effects

What causes us to age? New “clocks” developed by researchers may help point to the answers. Investigators from Brigham and Women’s Hospital, a founding member

February 15, 2024

Psychiatrist’s Alleged Fraud Scheme; ‘Girl Dinner’ Harmful? More PPD Zuranolone Data

An Arkansas psychiatrist allegedly held at least 26 former patients imprisoned as part of a Medicaid fraud scheme, according to a lawsuit. (NBC News) Children

July 27, 2023

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.